Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

3.1K
Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
3.1K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

12.9K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
12.9K
Mitochondria01:37

Mitochondria

12.1K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
12.1K
ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

14.5K
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
14.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PARP1 deficiency mitigates amyloid pathology, neurodegeneration, and cognitive decline in a familial Alzheimer's disease model.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Machine learning model based on plasma proteomics for the identification of Parkinson's disease.

Brain : a journal of neurology·2026
Same author

MIF Tautomerase Inhibition Protects Neurons From Immune-Mediated Cell Death.

Neurology(R) neuroimmunology & neuroinflammation·2026
Same author

Author Correction: Autoimmune neuroinflammation leads to neuronal death via MIF nuclease-mediated parthanatos.

Nature neuroscience·2026
Same author

Gut-initiated alpha synuclein fibrils drive parkinsonism phenotypes: temporal mapping of REM sleep behavior disorder-like and other non-motor symptoms.

Translational neurodegeneration·2026
Same author

Autoimmune neuroinflammation leads to neuronal death via MIF nuclease-mediated parthanatos.

Nature neuroscience·2026

Related Experiment Video

Updated: Jun 23, 2025

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

1.5K

Enhancing mitochondrial proteolysis alleviates alpha-synuclein-mediated cellular toxicity.

Xi Zhang1,2, Linhao Ruan1, Hu Wang3,4

  • 1Center for Cell Dynamics, Department of Cell Biology, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.

NPJ Parkinson'S Disease
|June 21, 2024
PubMed
Summary
This summary is machine-generated.

Alpha-synuclein (α-Syn) enters mitochondria, causing dysfunction and cellular decline in Parkinson's disease (PD). Enhancing mitochondrial protein degradation offers a potential therapeutic strategy for neurodegenerative diseases like PD.

More Related Videos

A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model
08:24

A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model

Published on: November 25, 2022

2.2K
Author Spotlight: Decoding Mitochondrial Aging
08:48

Author Spotlight: Decoding Mitochondrial Aging

Published on: June 30, 2023

3.8K

Related Experiment Videos

Last Updated: Jun 23, 2025

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

1.5K
A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model
08:24

A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model

Published on: November 25, 2022

2.2K
Author Spotlight: Decoding Mitochondrial Aging
08:48

Author Spotlight: Decoding Mitochondrial Aging

Published on: June 30, 2023

3.8K

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • Parkinson's disease (PD) involves mitochondrial dysfunction and alpha-synuclein (α-Syn) aggregation.
  • The precise mechanisms linking α-Syn to mitochondrial damage are not fully understood.

Purpose of the Study:

  • To investigate the role of α-Syn import into mitochondria in causing cellular dysfunction.
  • To identify potential therapeutic targets for α-synucleinopathies.

Main Methods:

  • Investigated α-Syn import into mitochondria in yeast, human cells, and a transgenic mouse model.
  • Assessed the impact of α-Syn on mitochondrial function, including mtDNA, membrane potential, and cellular fitness.
  • Examined the role of mitochondrial proteases (NLN, PITRM1) in α-Syn degradation.
  • Tested the therapeutic potential of enhancing mitochondrial proteolysis.

Main Results:

  • α-Syn is constitutively imported into mitochondria in various cell types and accumulates with age in a PD mouse model.
  • Undegraded α-Syn in the mitochondrial matrix disrupts respiratory chain complexes, leading to mtDNA loss and reduced cellular fitness.
  • Increasing mitochondrial protease levels mitigated α-Syn-induced defects in yeast, human cells, and primary neurons.

Conclusions:

  • Directly links α-Syn import into mitochondria to cellular toxicity in Parkinson's disease.
  • Highlights mitochondrial proteolysis as a promising therapeutic avenue for α-synucleinopathies.